2025年3月11日， Nevro（NVRO）披露8笔公司内部人交易情况。董事Thornal Kevin R于2025年3月7日卖出2.70万股。 2025年3月11日 高管 SILLER GREG 2025年3月7日 卖出 1.15万 5.77 6.64万 2025年3月11日 高管 MacLeod Roderick H. 2025年3月7日 卖出 1.69万 5.77 9.75万 2025年3 ...

AUDUBON, PA & REDWOOD CITY, CA — Globus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp ... CEO and President Kevin Thornal stated, “We are ...

March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical ... and the benefits from our 2024 restructurings," said Kevin Thornal, Nevro's president and CEO. "Importantly, we look ...

March 4, 2025 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical ... the benefits from our 2024 restructurings,” said Kevin Thornal, Nevro’s president and CEO.

06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp ... of chronic pain,” said Kevin Thornal, Nevro’s CEO and President.

March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering ... reflecting our ongoing focus on working capital management and the benefits from our 2024 ...

MILWAUKEE, Feb. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical.